Adjuvance Technologies is a series a startup. 2 investors tracked. Status: possibledead.
Adjuvance Technologies is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Adjuvance Technologies develops innovative software tools to accelerate drug discovery by applying AI-driven analytics to biomedical data.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.